Shemesh, Rachel
Laufer-Geva, Smadar
Gorzalczany, Yaara
Anoze, Alaa
Sagi-Eisenberg, Ronit
Peled, Nir
Roisman, Laila C.
Article History
Received: 31 August 2023
Accepted: 27 November 2023
First Online: 6 December 2023
Competing interests
: N.P. has received honoraria and worked as advisor and researcher with AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Foundation Medicine, Guardant360, Imagene, Merck, MSD, Novartis, Novocure, Pfizer, Roche, Rhenium and Takeda. The other authors declare no competing interests.